France and Germany, on Monday, March 15, suspended the use of AstraZeneca COVID-19 vaccine after reported blood clotting incidents in Europe.
The President of France, Emmanuel Macron, said the suspension was only a precaution pending a review of its safety by the European Medicines Agency.
He told a press conference, “The decision has been made to suspend the use of the AstraZeneca vaccine as a precaution, hoping that we can resume it quickly if the judgement of the EMA allows it. An announcement by the EMA is expected on Tuesday afternoon. We have a simple guide, to be informed by science and the competent health authorities and to do it as part of a European strategy.”
The German health ministry also said, “After new reports of thromboses of the cerebral veins in connection with the vaccination in Germany and Europe, the PEI considers further investigations to be necessary. The European Medicines Agency (EMA) will decide whether and how the new findings will affect the approval of the vaccine.”
Also Read: NLC Urges Gov Fayemi to Pay Outstanding Workers’ Salaries before May 1